Compounds > hydroxyurea

hydroxyurea and 5-hydroxy-6,8,11,14-eicosatetraenoic acid

hydroxyurea has been researched along with 5-hydroxy-6,8,11,14-eicosatetraenoic acid in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (50.00)18.2507
2000's0 (0.00)29.6817
2010's2 (33.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Bukantz, SC1
Kimble, EF; Kowalski, TJ; Peters, PA; Powers, C; Satoh, Y; Toledo, LM1
Fitzpatrick, FA; Lepley, RA1
Cao, R; Liu, T; Meng, Z; Wang, X; Wang, Y; Yang, Z1
Fan, B; Gao, W; Li, B; Li, M; Liu, H; Qu, X; Shao, Q; Wang, Q; Wen, Z; Xie, Q; Yang, Y; Yu, J; Zhao, F1
Duan, P; Lin, J; Long, J; Tang, J; Zhang, C; Zhu, H1

Other Studies

6 other study(ies) available for hydroxyurea and 5-hydroxy-6,8,11,14-eicosatetraenoic acid

ArticleYear
Asthma: the molecular light at the end of the tracheal tunnel.
    Hospital practice (Office ed.), 1991, Feb-15, Volume: 26, Issue:2

    Topics: Asthma; Humans; Hydroxyeicosatetraenoic Acids; Hydroxyurea; Leukotrienes; Lipoxygenase Inhibitors; Propionates; Quinolines

1991
Derivatives of 2-[[N-(Aminocarbonyl)-N-hydroxyamino]methyl]-1,4- benzodioxan as orally active 5-lipoxygenase inhibitors.
    Journal of medicinal chemistry, 1995, Jan-06, Volume: 38, Issue:1

    Topics: Administration, Oral; Animals; Dioxanes; Dogs; Guinea Pigs; Hydroxyeicosatetraenoic Acids; Hydroxyurea; Leukotriene B4; Lipoxygenase Inhibitors; Neutrophils; Stereoisomerism

1995
Irreversible inactivation of 5-lipoxygenase by leukotriene A4. Characterization of product inactivation with purified enzyme and intact leukocytes.
    The Journal of biological chemistry, 1994, Jan-28, Volume: 269, Issue:4

    Topics: Arachidonate 5-Lipoxygenase; Cell Differentiation; Cell Line; Humans; Hydroxyeicosatetraenoic Acids; Hydroxyurea; Kinetics; Leukemia, Promyelocytic, Acute; Leukocytes; Leukotriene A4; Lipoxygenase Inhibitors; Neutrophils; Tumor Cells, Cultured

1994
Inhibitor of 5-lipoxygenase, zileuton, suppresses prostate cancer metastasis by upregulating E-cadherin and paxillin.
    Urology, 2013, Volume: 82, Issue:6

    Topics: Animals; Arachidonate 5-Lipoxygenase; Cadherins; Cell Migration Assays; Enzyme-Linked Immunosorbent Assay; Humans; Hydroxyeicosatetraenoic Acids; Hydroxyurea; Immunohistochemistry; Lipoxygenase Inhibitors; Male; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Paxillin; Prostatic Neoplasms; Up-Regulation

2013
Increased metabolites of 5-lipoxygenase from hypoxic ovarian cancer cells promote tumor-associated macrophage infiltration.
    Oncogene, 2015, Mar-05, Volume: 34, Issue:10

    Topics: Animals; Arachidonate 5-Lipoxygenase; Cell Line; Cell Line, Tumor; Chemotaxis, Leukocyte; Disease Models, Animal; Female; Heparin-binding EGF-like Growth Factor; Heterografts; Humans; Hydroxyeicosatetraenoic Acids; Hydroxyurea; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Leukotriene B4; Macrophages; MAP Kinase Signaling System; Matrix Metalloproteinase 7; Mice; Neoplasm Metastasis; Ovarian Neoplasms; Tumor Necrosis Factor-alpha

2015
ALOX5-5-HETE promotes gastric cancer growth and alleviates chemotherapy toxicity via MEK/ERK activation.
    Cancer medicine, 2021, Volume: 10, Issue:15

    Topics: Analysis of Variance; Antineoplastic Agents; Arachidonate 5-Lipoxygenase; Cell Proliferation; Cell Survival; Disease Progression; Humans; Hydroxyeicosatetraenoic Acids; Hydroxyurea; Lipoxygenase Inhibitors; MAP Kinase Signaling System; Phosphorylation; Stomach Neoplasms; Up-Regulation

2021